Neuroprotective evaluation of zonisamide in patients with Parkinson's disease, using dopamine transporter scan (DAT scan)
Phase of Trial: Phase IV
Latest Information Update: 17 Aug 2017
At a glance
- Drugs Zonisamide (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- 07 Aug 2017 Status changed from recruiting to completed.
- 17 Nov 2016 Status changed from not yet recruiting to recruiting.
- 22 Jun 2016 New trial record